Lee Anselm Chi-Wai
Children's Haematology and Cancer Centre, Mount Elizabeth Hospital, Singapore.
Singapore Med J. 2018 Jul;59(7):390-393. doi: 10.11622/smedj.2018089.
Childhood immune thrombocytopenia (ITP) remains a diagnosis of exclusion when isolated thrombocytopenia is not part of another disease process. In practice, the diagnosis of ITP can only be confirmed when thrombocytopenia resolves or is excluded after the recognition of a primary cause.
The records of 87 consecutive children with isolated thrombocytopenia seen over a nine-year period in a private paediatric haematology practice were reviewed retrospectively. Children in whom a primary cause was eventually found were the subjects of a further descriptive study.
9 (10%) children with isolated thrombocytopenia were not diagnosed with ITP because a primary disease was found. Of these nine cases, four had thrombocytopenia recognised during the neonatal period, consisting of perinatal cytomegalovirus infection (n = 2), meconium aspiration pneumonia (n = 1) and transient abnormal myelopoiesis associated with Down syndrome (n = 1). The remaining five children were each found to have familial thrombocytopenia, portal hypertension, cutaneous mastocytosis, May-Hegglin anomaly and systemic lupus erythematosus. Two of them had a history of failure of response to corticosteroid therapy.
Secondary thrombocytopenia is not uncommon in a tertiary paediatric specialty practice with adequate evaluation. Thrombocytopenia occurring during the newborn period and failure of steroid therapy are predictive of secondary cases.
当孤立性血小板减少症并非其他疾病过程的一部分时,儿童免疫性血小板减少症(ITP)仍需排除其他病因后才能确诊。在实际临床中,只有在识别出原发性病因后血小板减少症得到缓解或排除,ITP的诊断才能得以确认。
回顾性分析一家私立儿科血液科诊所九年间连续收治的87例孤立性血小板减少症患儿的病历。最终发现原发性病因的患儿纳入进一步的描述性研究。
9例(10%)孤立性血小板减少症患儿未被诊断为ITP,因为发现了原发性疾病。这9例中,4例在新生儿期发现血小板减少,包括围生期巨细胞病毒感染(2例)、胎粪吸入性肺炎(1例)以及与唐氏综合征相关的短暂异常骨髓造血(1例)。其余5例患儿分别被诊断为家族性血小板减少症、门静脉高压、皮肤肥大细胞增多症、May-Hegglin异常和系统性红斑狼疮。其中2例有对皮质类固醇治疗反应不佳的病史。
在经过充分评估的三级儿科专科诊所中,继发性血小板减少症并不罕见。新生儿期出现的血小板减少症以及类固醇治疗无效是继发性病例的预测因素。